NCT02584647 2025-03-21
PLX3397
Columbia University
Phase 1/2 Terminated
Clinical Trials
4 trialsNCT02452424 2020-03-05
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors
Daiichi Sankyo
Phase 1/2 Terminated
NCT01499043 2020-03-04
Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)
Daiichi Sankyo
Phase 2 Terminated
NCT01349036 2020-03-03
A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
Daiichi Sankyo
Phase 2 Terminated